Interleukin-6 is a prognostic factor in multiple myeloma. 1991

H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber

UI MeSH Term Description Entries
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
May 1996, British journal of haematology,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
February 1996, British journal of haematology,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
July 1989, Blood,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
December 2010, Experimental hematology,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
October 2001, Blood,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
December 2006, Blood,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
May 1992, Medicina clinica,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
February 1995, Blood,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
January 1990, European cytokine network,
H Ludwig, and D M Nachbaur, and E Fritz, and M Krainer, and H Huber
May 1998, Cancer,
Copied contents to your clipboard!